Clinical Trial: Study of Oglemilast for the Prevention of Asthma.

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Efficacy and Safety of Oglemilast in the Prevention of Exercise-Induced Bronchospasm

Brief Summary: The purpose of this study is to determine whether it is effective in the treatment of exercise-induced asthma and investigate the safety of oglemilast.

Detailed Summary:
Sponsor: Forest Laboratories

Current Primary Outcome: To determine the efficacy of oglemilast as compared to placebo in preventing exercise-induced asthma following 15 days of treatment.

Original Primary Outcome: Same as current

Current Secondary Outcome: To evaluate the safety of oglemilast over 2 weeks as determined by adverse events, physical examinations, vital signs, electrocardiograms, and laboratory examinations.

Original Secondary Outcome: Same as current

Information By: Forest Laboratories

Dates:
Date Received: May 4, 2006
Date Started: May 2006
Date Completion:
Last Updated: April 7, 2012
Last Verified: April 2012